Orlistat
FIT-PLESE
Empros Pharma AB · Phase 3 · Completed · Enrollment 379
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Intensive Lifestyle Mod. Intervention | n/r | n/r | n/r | n/r |
| Standard Lifestyle Intervention | n/r | n/r | n/r | n/r |
Not shown
- Intensive Lifestyle Mod. Intervention: endpoint not reported
- Standard Lifestyle Intervention: endpoint not reported